Press release: WHO finishes this week its historic review of cannabis #ECDD41


05 December, 2018

This week at the headquarters of WHO (World Health Organization) in Geneva (Switzerland), the Expert Committee on Drug Dependence (ECDD) meets to undertake the final part of the scientific review of cannabis, resin, extracts, THC, and CBD extracts [1]. Their outcome is likely to change the scheduling status of cannabis within the international drug control Treaties [2].

WHO never updated its policy on cannabis since 1954 [3] – although THC was identified in 1964 and its mechanisms of action on the human body, in 1994.

On Monday, Dr. Mariângela Simão, WHO Assistant Director-General for Drugs & Medicines, convened a public hearing, where civil society stakeholders could address the ECDD Experts before they started their closed-doors scientific assessment of the plant, heavily scheduled in the Treaties.

Read the full article